Logo Logo
Help
Contact
Switch Language to German

Xiong, Yuqing ORCID logoORCID: https://orcid.org/0009-0009-2193-1246; Rabe, Moritz ORCID logoORCID: https://orcid.org/0000-0002-7085-4066; Rippke, Carolin ORCID logoORCID: https://orcid.org/0000-0002-6519-928X; Kawula, Maria ORCID logoORCID: https://orcid.org/0000-0002-5039-8278; Nierer, Lukas; Klüter, Sebastian ORCID logoORCID: https://orcid.org/0000-0003-3139-3444; Belka, Claus ORCID logoORCID: https://orcid.org/0000-0002-1287-7825; Niyazi, Maximilian; Hörner-Rieber, Juliane ORCID logoORCID: https://orcid.org/0000-0003-3911-4438; Corradini, Stefanie ORCID logoORCID: https://orcid.org/0000-0001-8709-7252; Landry, Guillaume ORCID logoORCID: https://orcid.org/0000-0003-1707-4068 and Kurz, Christopher (2024): Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer. In: Physics and Imaging in Radiation Oncology, Vol. 29, 100562 [PDF, 3MB]

[thumbnail of 1-s2.0-S2405631624000320-main.pdf]
Preview
Creative Commons Attribution
Published Version
Download (3MB)

Abstract

Background and purpose: Ultra-hypofractionated online adaptive magnetic resonance-guided radiotherapy (MRgRT) is promising for prostate cancer. However, the impact of online adaptation on target coverage and organ-at-risk (OAR) sparing at the level of accumulated dose has not yet been reported. Using deformable image registration (DIR)-based accumulation, we compared the delivered adapted dose with the simulated non-adapted dose. Materials and methods: Twenty-three prostate cancer patients treated at two clinics with 0.35 T magnetic resonance-guided linear accelerator (MR-linac) following the same treatment protocol (5 × 7.5 Gy with urethral sparing and daily adaptation) were included. The fraction MR images were deformably registered to the planning MR image. Both non-adapted and adapted fraction doses were accumulated with the corresponding vector fields. Two DIR approaches were implemented. PTV* (planning target volume minus urethra+2mm) D95%, CTV* (clinical target volume minus urethra) D98%, and OARs (urethra+2mm, bladder, and rectum) D0.2cc, were evaluated. Statistical significance was inferred from a two-tailed Wilcoxon signed-rank test (p < 0.05). Results: Normalized to the baseline, the accumulated PTV* D95% increased significantly by 2.7 % ([1.5, 4.3]%) through adaptation, and the CTV* D98% by 1.2 % ([0.1, 1.7]%). For the OARs after adaptation, accumulated bladder D0.2cc decreased by 0.4 % ([−1.2, 0.4]%), urethra+2mm D0.2cc by 0.8 % ([−1.6, −0.1]%), while rectum D0.2cc increased by 2.6 % ([1.2, 4.9]%). For all patients, rectum D0.2cc was still below the clinical constraint. Results of both DIR approaches differed on average by less than 0.2 %. Conclusions: Online adaptation in MRgRT improved target coverage and OARs sparing at the level of accumulated dose.

Actions (login required)

View Item View Item